OXT and hemorrhage: <h4>Background</h4>To assess the equivalence of tranexamic acid (TRAN) versus synthetic oxytocin (OXY) in reducing post-partum blood loss, in full-term patients (37-42 weeks), at low risk of post-partum hemorrhage, with vaginal childbirth.<h4>Methods</h4>Phase III, randomized (1:1), open-label, longitudinal, multi-center, prospective clinical trial (Prot.